A pivotal role for galectin-1 in fetomaternal tolerance

  • Sandra M Blois
  • Juan M Ilarregui
  • Mareike Tometten
  • Mariana Garcia
  • Arif S Orsal
  • Rosalia Cordo-Russo
  • Marta A Toscano
  • Germán A Bianco
  • Peter Kobelt
  • Bori Handjiski
  • Irene Tirado
  • Udo R Markert
  • Burghard F Klapp
  • Francoise Poirier
  • Julia Szekeres-Bartho
  • Gabriel A Rabinovich
  • Petra C Arck

Abstract

A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1-deficient (Lgals1-/-) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)-secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.

Bibliographical data

Original languageEnglish
ISSN1078-8956
DOIs
Publication statusPublished - 12.2007
PubMed 18026113